Drug major Dr Reddy's Laboratories Tuesday said it has launched Colesevelam Hydrochloride tablets, used for lowering of cholesterol, in the US market.
The company has launched generic Colesevelam Hydrochloride tablets USP in the US market after getting approval from the US Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a BSE filing.
The tablets are generic version of Daiichi Sankyo Inc's Welchol tablets, it added.
According to the IMS Health data, the Welchol brand and generic had the US sales of around USD 471 million MAT for the most recent 12 months ending in August 2018, Dr Reddy's Laboratories said.
Colesevelam Hydrochloride tablets along with diet and exercise, lower low-density lipoprotein cholesterol.
Shares of Dr Reddy's Laboratories closed at Rs 2,446.60 per scrip on the BSE, up 4.60 per cent from its previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
